Fundraising Fox
🦊/Companies
Sign in

Rycarma

New York, US · 2 known investors

Find your way into Rycarma

RyCarma Therapeutics develops a novel drug class called Rycals to treat orphan skeletal muscle and cardiac diseases, building on foundational cardiovascular research and drug-delivery technologies.

BiotechHealthtechMedical Devices

Founders & leadership

ARAndrew R. Marks
Andrew R. MarksFounding Scientist, MD

Investors · 2

Kurma PartnersParis · $162K – $10.8M
Pontifax Venture CapitalHerzeliya · $6.3M – $128M

Frequently asked questions

What does Rycarma do?
RyCarma Therapeutics develops a novel drug class called Rycals to treat orphan skeletal muscle and cardiac diseases, building on foundational cardiovascular research and drug-delivery technologies.
Who founded Rycarma?
Rycarma was founded by Andrew R. Marks.
Who are Rycarma's investors?
Rycarma's investors include Kurma Partners, Pontifax Venture Capital.
Where is Rycarma headquartered?
Rycarma is headquartered in New York, US.